BMY : Summary for Bristol-Myers Squibb Company Co - Yahoo Finance

U.S. Markets open in 6 hrs 53 mins

Bristol-Myers Squibb Company (BMY)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
56.07-0.21 (-0.37%)
At close: 4:00PM EST
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close56.28
Bid0.00 x
Ask0.00 x
Day's Range55.89 - 56.55
52 Week Range49.03 - 77.12
Avg. Volume10,100,983
Market Cap93.71B
PE Ratio (TTM)28.05
Earnings DateN/A
Dividend & Yield1.56 (2.77%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • TheStreet.com2 days ago

    Why Bristol-Myers Squibb May Be a Merger Target Soon

    The $101 billion market cap pharma could be put in play or targeted by an activist investor soon.

  • Investopedia3 days ago

    These 5 Drug Patents Will Expire in 2017

    Investopedia looks at the top drug patents about to expire in 2017

  • Bristol-Myers Squibb Co. – Value Analysis (NYSE:BMY) : January 13, 2017
    Capital Cube6 days ago

    Bristol-Myers Squibb Co. – Value Analysis (NYSE:BMY) : January 13, 2017

    Categories: Fundamental Analysis Yahoo Finance Click here to see latest analysis Capitalcube gives Bristol-Myers Squibb Co. a score of 72. Our analysis is based on comparing Bristol-Myers Squibb Co. with the following peers – Pfizer Inc., Merck & Co., Inc., Eli Lilly and Company, Novartis AG Sponsored ADR, Sanofi Sponsored ADR, Astrazeneca PLC Sponsored ADR, Johnson & Johnson, AbbVie, Inc., ... Read more (Read more...)